Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yam Nath Paudel's publication output changed over time?
ScholarIQpublication output · 2018–2022
Output declined50% over the shown period — from 2 works in 2018 to 1 in 2022.
2
3
4
1
1
20182019202020212022
What are the most-cited papers on Yam Nath Paudel?
ScholarIQmost cited works
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
Yam Nath Paudel, Mohd. Farooq Shaikh, Ayanabha Chakraborti, Yatinesh Kumari, Ángel Aledo‐Serrano, Katina Aleksovska, Marina Koutsodontis Machado Alvim, Iekhsan Othman
S115201632. 2018318 CitationsOPEN ACCESS
Revisiting the role of neurotransmitters in epilepsy: An updated review
Enes Akyüz, Ayse Kristina Polat, Ece Eroğlu, İ̇rem Küllü, Efthalia Angelopoulou, Yam Nath Paudel
Life Sciences. 2020299 Citations
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Khurram Aamir, Mohd. Farooq Shaikh
S2736626452. 2020255 CitationsOPEN ACCESS
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Vinod Balasubramaniam, Iekhsan Othman, Mohd. Farooq Shaikh
European Journal of Pharmacology. 2019175 Citations
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Pharmacological Research. 2019147 Citations
Related on ScholarIQ
Virginia Commonwealth University
Institution
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
Paper
Revisiting the role of neurotransmitters in epilepsy: An updated review
Paper
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Paper
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
Paper
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Paper